Thomas Waerner
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Protein purification and stability 6
- Viral Infectious Diseases and Gene Expression in Insects 5
- Angiogenesis and VEGF in Cancer 1
-
- Biosimilars and Bioanalytical Methods 4
- Co-authors
- Hartmut Beug (4 shared papers)Martin Jechlinger (3 shared papers)Andreas Weith (3 shared papers)Norbert Kraut (2 shared papers)Peter Seither (1 shared paper)Elżbieta Janda (1 shared paper)Susanna K. Lüdemann (1 shared paper)Stefan Grünert (1 shared paper)
- Journals
- Biotechnology Progress (2 papers)Biotechnology and Bioengineering (2 papers)Oncogene (2 papers)Frontiers in Bioengineering and Biotechnology (1 paper)mAbs (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Thomas Waerner
13 papers receiving 874 citations
Peers
Comparison fields: 5 of 76
- Oncology 281
- Cancer Research 126
- Molecular Biology 602
- Radiology, Nuclear Medicine and Imaging 129
- Hepatology 37
Countries citing papers authored by Thomas Waerner
This map shows the geographic impact of Thomas Waerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Waerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Waerner more than expected).
Fields of papers citing papers by Thomas Waerner
This network shows the impact of papers produced by Thomas Waerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Waerner. The network helps show where Thomas Waerner may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Waerner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 231 | |
| 2 | 2006 | 172 | |
| 3 | 2006 | 150 | |
| 4 | 2021 | 118 | |
| 5 | 2018 | 90 | |
| 6 | Human RERE is localized to nuclear promyelocytic leukemia oncogenic domains and enhances apoptosis. | 2001 | 44 |
| 7 | 2008 | 31 | |
| 8 | 2019 | 20 | |
| 9 | 2010 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2025 | 7 | |
| 12 | 2007 | 4 | |
| 13 | 2025 | 1 |
About Thomas Waerner
Thomas Waerner is a scholar working on Molecular Biology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 13 papers that have together received 890 indexed citations. Recurring topics across this work include Protein purification and stability (6 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), Biosimilars and Bioanalytical Methods (4 papers), Cancer Cells and Metastasis (3 papers), 3D Printing in Biomedical Research (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Angiogenesis and VEGF in Cancer (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (281 citations), Cancer Research (126 citations), Molecular Biology (602 citations), Radiology, Nuclear Medicine and Imaging (129 citations) and Hepatology (37 citations). Thomas Waerner has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Hartmut Beug, Martin Jechlinger, Andreas Weith, Norbert Kraut, Peter Seither, Elżbieta Janda, Susanna K. Lüdemann, Stefan Grünert, Martin Vanderlaan and Annamaria Gal. Their work appears in journals such as Biotechnology Progress, Biotechnology and Bioengineering, Oncogene, Frontiers in Bioengineering and Biotechnology and mAbs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.